Course Disclaimer
The Top 250 Drugs is an educational learning tool only. It is NOT a comprehension resource for drug information. Drug and disease state information have been intentionally abbreviated, simplified, and generalized to facilitate a strong foundational understanding. The content provided in this course is for educational and informational purposes only, and no guarantee or warranty is made that the information is error-free. While every attempt has been made to provide accurate and complete information, information fidelity may be lost in the process of simplifying difficult concepts or terms.
Module 1 | Cardiovascular Drugs | |
---|---|---|
Unit 1 | 01.01 - Renin-Angiotensin-Aldosterone System | |
Unit 2 | 01.02 - Beta Blockers | |
Unit 3 | 01.03 - Calcium Channel Blockers | |
Unit 4 | 01.04 - Diuretics | |
Unit 5 | 01.05 - Statins | |
Unit 6 | 01.06 - Other Agents for Dyslipidemias | |
Unit 7 | 01.07 - Antiplatelets | |
Unit 8 | 01.08 - Traditional Anticoagulants | |
Unit 9 | 01.09 - Novel Oral Anticoagulants | |
Unit 10 | 01.10 - Antianginals | |
Unit 11 | 01.11 - Other Cardiovascular Agents | |
Module 2 | Respiratory Drugs | |
Unit 1 | 02.01 - Inhaled Corticosteroids and Long-Acting Beta Agonists | |
Unit 2 | 02.02 - Short-Acting Beta Agonists and Anticholinergics | |
Unit 3 | 02.03 - Other Respiratory Agents | |
Module 3 | Gastrointestinal Drugs | |
Unit 1 | 03.01 - Proton Pump Inhibitors | |
Unit 2 | 03.02 - Histamine (H2) Receptor Blockers | |
Unit 3 | 03.03 - Laxatives | |
Unit 4 | 03.04 - Diarrhea and Ulcerative Colitis | |
Unit 5 | 03.05 - Nausea | |
Module 4 | Renal Drugs | |
Unit 1 | 04.01 - Renal Medications | |
Unit 2 | 04.02 - Erythropoiesis-Stimulating Agents | |
Module 5 | Neurologic Drugs | |
Unit 1 | 05.01 - Headache | |
Unit 2 | 05.02 - Epilepsy | |
Unit 3 | 05.03 - Opioid Analgesics | |
Unit 4 | 05.04 - Non-Steroidal Anti-inflammatory Drugs | |
Unit 5 | 05.05 - Muscle Relaxants | |
Unit 6 | 05.06 - Adjunct Medications for Pain | |
Unit 7 | 05.07 - Alzheimer's Disease | |
Unit 8 | 05.08 - Smoking Cessation | |
Module 6 | Psychiatric Drugs | |
Unit 1 | 06.01 - Atypical Antipsychotics | |
Unit 2 | 06.02 - Benzodiazepines | |
Unit 3 | 06.03 - Selective Serotonin Reuptake Inhibitors | |
Unit 4 | 06.04 - Serotonin-Norepinephrine Reuptake Inhibitors | |
Unit 5 | 06.05 - Non-Benzodiazepine Hypnotics | |
Unit 6 | 06.06 - Other Antidepressants and Anti-Anxiety Agents | |
Unit 7 | 06.07 - Stimulants and ADHD Agents | |
Module 7 | Endocrinology Drugs | |
Unit 1 | 07.01 - Diabetes - Oral Agents I | |
Unit 2 | 07.02 - Diabetes - Oral Agents II | |
Unit 3 | 07.03 - Diabetes - Injectable Agents | |
Unit 4 | 07.04 - Contraceptives | |
Unit 5 | 07.05 - Corticosteroids | |
Unit 6 | 07.06 - Hormonal Therapy | |
Module 8 | Urologic Drugs | |
Unit 1 | 08.01 - Alpha Blockers | |
Unit 2 | 08.02 - 5-Alpha Reductase Inhibitors | |
Unit 3 | 08.03 - Erectile Dysfunction | |
Unit 4 | 08.04 - Overactive Bladder | |
Module 9 | Rheumatologic Drugs | |
Unit 1 | 09.01 - Osteoporosis | |
Unit 2 | 09.02 - Rheumatoid Arthritis | |
Unit 3 | 09.03 - Gout | |
Module 10 | Ophthalmic and Otolaryngological Drugs | |
Unit 1 | 10.01 - Allergies | |
Unit 2 | 10.02 - Nasal Corticosteroids | |
Unit 3 | 10.03 - Cough and Cold | |
Unit 4 | 10.04 - Glaucoma | |
Unit 5 | 10.05 - Other Ophthalmic Agents | |
Module 11 | Dermatologic Drugs | |
Unit 1 | 11.01 - Acne Vulgaris | |
Module 12 | Infectious Disease Drugs | |
Unit 1 | 12.01 - B-Lactam Antibiotics | |
Unit 2 | 12.02 - Fluoroquinolones | |
Unit 3 | 12.03 - Macrolides | |
Unit 4 | 12.04 - Other Antibiotics I | |
Unit 5 | 12.05 - Other Antibiotics II | |
Unit 6 | 12.06 - Antifungals | |
Unit 7 | 12.07 - Influenza and Herpes Simplex Antivirals | |
Unit 8 | 12.08 - Human Immunodeficiency Virus Antivirals | |
Module 13 | Final Exam and Feedback | |
Unit 1 | Final Exam | |
Unit 2 | End of Course Survey |